Oxiracetam

Bezeichnung:Oxiracetam

CAS-Nr62613-82-5

Englisch Name:Oxiracetam

CBNumberCB3328242

SummenformelC6H10N2O3

Molgewicht158.16

MOL-Datei62613-82-5.mol

Oxiracetam physikalisch-chemischer Eigenschaften

Schmelzpunkt	165-168 °C
Siedepunkt	494.6±40.0 °C(Predicted)
Dichte	1.416
storage temp.	Sealed in dry,Room Temperature
Löslichkeit	DMSO (Slightly, Heated), Methanol (Slightly, Heated)
pka	13.76±0.20(Predicted)
Aggregatzustand	Solid
Farbe	White to Off-White
Merck	14,6942
InChI	InChI=1S/C6H10N2O3/c7-5(10)3-8-2-4(9)1-6(8)11/h4,9H,1-3H2,(H2,7,10)
InChIKey	IHLAQQPQKRMGSS-UHFFFAOYSA-N
SMILES	N1(CC(N)=O)CC(O)CC1=O
CAS Datenbank	62613-82-5(CAS DataBase Reference)

Sicherheit

Kennzeichnung gefährlicher	Xi
R-Sätze:	36/38
S-Sätze:	26-36
WGK Germany	3
RTECS-Nr.	UX9656638
HS Code	2933.79.8500

Gefahreninformationscode (GHS)

Oxiracetam Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:
R36/38:Reizt die Augen und die Haut.
S-Sätze Betriebsanweisung:
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
Beschreibung
Oxiracetam is a structural analogue of piracetam. This compound has enhancing effects on vigilance and memory. In comparison with piracetam, oxiracetam exhibits greater improvement in memory (Itil et al., 1986) and has been used extensively for the treatment of dementia, including AD, VaD, MID (Baumel et al., 1989; Dysken et al., 1989), and mixed forms. Green et al. (1992) failed to demonstrate a difference from placebo in AD patients. In contrast, Maina et al. (1989) studied 289 patients with MID in a double-blind placebo-controlled trial and after 12 weeks of treatment found that oxiracetam reduced behavioural symptoms.
Chemische Eigenschaften
Whie Solid
Originator
ISF (Italy)
Verwenden
Oxiracetam is a 4-hydroxy analog of piracetam with psychostimulant activity, reportedly useful in relieving the symptoms of cerebral insufficiency in the elderly.
Definition
ChEBI: Oxiracetam is an organooxygen compound and an organonitrogen compound. It is functionally related to an alpha-amino acid.
Trademarks
Neuromet
Biochem/physiol Actions
Nootropic agent, improves learning and memory, and prevents impairment of cognitive functions. Its mechanism of action in not yet known, but it is suggested to modulate glutamatergic and cholinergic neurotransmission. Protein kinase C may be involved.
läuterung methode
This nootropic (Alzheimer) drug is purified by recrystallisation from MeOH or aqueous Me2CO and dried in vacuo. [NMR, IR: Pifferi & Pinza Farmaco Ed Sci 32 602 1977, Banfi et al. Farmaco Ed Sci 39 16 1984, Gouilaev & Senning Brain Research Rev 19 180 1994.]

Oxiracetam Upstream-Materialien And Downstream Produkte

Oxiracetam Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

62613-82-5, Oxiracetam Verwandte Suche:

Send Inquriy